CTI BioPharma | Investor Presentation Deck | 24 slides

CTI BioPharma · 2022-09
arc beats above · slides in the middle · loops below · scroll → 3 LOOPS
SETUP TENSION ANALYSIS EVIDENCE RESOLUTION APPENDIX
HOVER FOR DETAILS · CLICK A SLIDE FOR FULLSCREEN · STEP 1
No image bound to this slide. Wire up imgproxy to display the rendered slide JPEG.

Deck intelligence map

6
coverage by narrative range · generated from this deck JSON

Slide inventory

24
every slide · same image gating as the playbook
01
Slide 1
Exhibit 99.1 indicates this is likely a public filing or investor relations document.front_matter
Open slide detailBeat · Setup
02
other
Open slide detailBeat · Setup
03
Slide provides a snapshot of product approval, financial performance, and market opportunity.summarize
Open slide detailBeat · SetupLoop · Golden Circle
04
Includes market sizing data and clinical characteristics of the target patient segment.size_opportunity
05
The slide uses a combination of real-world dosing data and HCP satisfaction surveys to argue that the current standard of care (Jakafi) is being used ineffectivframe_problem
Open slide detailBeat · ComplicationLoop · Cost Of Inaction
06
The slide uses a biological pathway diagram to explain the mechanism of action.present_solution
Open slide detailBeat · SolutionLoop · Cost Of Inaction
07
Includes product packaging imagery and regulatory status summary.appendix
08
Includes clinical trial data from PERSIST-2 study.analyze_data
09
The slide outlines a randomized controlled trial design for Myelofibrosis treatment.present_framework
Open slide detailBeat · Evidence
10
The slide uses a process flow diagram to represent clinical trial methodology.present_framework
Open slide detailBeat · Evidence
11
Includes two charts: a bar chart for SVR achievement and a waterfall plot for median percentage change in spleen volume.show_traction
Open slide detailBeat · Evidence
12
Includes a bar chart for response rates and a waterfall plot for individual patient symptom changes.show_traction
Open slide detailBeat · Evidence
13
The slide uses three bar charts to illustrate clinical efficacy endpoints related to anemia in a specific patient population.show_traction
Open slide detailBeat · Evidence
14
Data presented as median values with interquartile ranges (IQR).show_traction
Open slide detailBeat · Evidence
15
The slide presents data from a retrospective analysis of the PERSIST-2 trial.analyze_data
16
The slide uses a biological process diagram to explain the mechanism of action.present_solution
17
The slide compares two different clinical trial datasets (PERSIST-2 vs MOMENTUM) to highlight efficacy.compare_peers
18
plan_implementation
Open slide detailBeat · Go-to-MarketLoop · Quick Win Big Bet
19
Slide emphasizes clinical validation and market positioning via guideline inclusion.show_traction
Open slide detailBeat · Go-to-MarketLoop · Quick Win Big Bet
20
plan_implementation
Open slide detailBeat · Go-to-MarketLoop · Quick Win Big Bet
21
The slide uses a three-column layout to summarize key product benefits.present_solution
22
The slide highlights financial stability to support commercialization efforts.analyze_data
23
The slide uses a three-column layout to summarize key business pillars.summarize